Genitourinary Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Genitourinary
| Protocol | EA8153 |
|---|---|
| Cancer Type: | Prostate |
| Fast Facts |
Cabazitaxel With Abiraterone Versus Abiraterone Alone Randomized Trial for Extensive Disease Following Docetaxel: The CHAARTED2 Trial
| Protocol | NRG GU002 |
|---|---|
| Cancer Type: | Prostate |
| Fast Facts |
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy with or Without Adjuvant Docetaxel
| Protocol | NRG GU005 |
|---|---|
| Cancer Type: | Prostate Cancer |
| Fast Facts |
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
| Protocol | SWOG S1802 |
|---|---|
| Cancer Type: | Metastatic Prostate Cancer |
| Fast Facts |
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | Alliance A031704 |
|---|---|
| Cancer Type: | METASTATIC UNTREATED RENAL CELL |
| Fast Facts |
|
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell Cancer [PDIGREE] |
| Protocol | EA8143 |
|---|---|
| Cancer Type: | Renal Cell |
| Fast Facts |
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients with Renal Cell Carcinoma Undergoing Nephrectomy
(PROSPER RCC)
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | Alliance A031501 |
|---|---|
| Cancer Type: | ADVANCED UROTHELIAL CARCINOMA |
| Fast Facts |
Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (AMBASSADOR) Versus Observation
| Protocol | SWOG S1806 |
|---|---|
| Cancer Type: | Bladder Cancer |
| Fast Facts |
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab In Localized Muscle Invasive Bladder Cancer
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | Alliance A031102 |
|---|---|
| Cancer Type: | Germ Cell Tumor |
| Fast Facts |
A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors
Please check out the rare protocol list to locate other studies within this disease site.
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | WF 1802 |
|---|---|
| Cancer Type: | Prostate Cancer |
| Fast Facts |
Influence of Primary Treatment for Prostate Cancer on Work Experience (PCW)
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | NRG CC007CD |
|---|---|
| Cancer Type: | Prostate Cancer |
| Fast Facts |
Increasing the Dose of Survivorship Care Planning In Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | COG AREN03B2 |
|---|---|
| Cancer Type: | Renal-Biology |
| Fast Facts |
Renal Tumors Classification, Biology, and Banking Study
TEMPORARY CLOSURE
Patients must be < 30 Years Old at the Time of Diagnosis.
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
